Literature DB >> 15734441

Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation.

Yoshifumi Sano1, Hiroshi Date, Itaru Nagahiro, Motoi Aoe, Nobuyoshi Shimizu.   

Abstract

We report a successful case of living-donor lobar lung transplantation (LDLLT) for severe bronchiolitis obliterans (BO) after bone marrow transplantation (BMT). The patient is a 29-year-old woman who underwent BMT because of aplastic anemia in 1995. In 1996, BO developed in the patient because of chronic graft-versus-host disease. In May 2000, a LDLLT was performed. Pulmonary function tests showed improvement of both vital capacity and forced expiratory volume in 1 second. At present, 91 months after BMT and 38 months after lung transplantation, the patient is in good health. LDLLT may offer a therapeutic option for the treatment of BO after BMT.

Entities:  

Mesh：

Year:  2005        PMID： 15734441     DOI： 10.1016/j.athoracsur.2003.09.111

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

2.  Living-donor single lobe lung transplantation for bronchiolitis obliterans from mother to child following previous allogeneic hematopoietic stem cell transplantation from the same donor.

Authors:  Koichi Oshima; Akira Kikuchi; Shinji Mochizuki; Masaomi Yamane; Hiroshi Date; Ryoji Hanada
Journal:  Int J Hematol       Date:  2009-10-29       Impact factor: 2.490

3.  Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation.

Authors:  R A Nash; M Yunosov; K Abrams; B Hwang; C Castilla-Llorente; P Chen; A S Farivar; G E Georges; R C Hackman; W J E Lamm; M Lesnikova; H D Ochs; J Randolph-Habecker; S F Ziegler; R Storb; B Storer; D K Madtes; R Glenny; M S Mulligan
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

4.  Favorable survival in lung transplant recipients on preoperative low-dose, as compared to high-dose corticosteroids, after hematopoietic stem cell transplantation.

Authors:  Seiichiro Sugimoto; Kentaroh Miyoshi; Takeshi Kurosaki; Shinji Otani; Masaomi Yamane; Motomu Kobayashi; Takahiro Oto
Journal:  Int J Hematol       Date:  2018-01-30       Impact factor: 2.490

5.  Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs?

Authors:  Hirokazu Okumura; Shigeki Ohtake; Yasuo Ontachi; Jun Ozaki; Shigeru Shimadoi; Yuko Waseda; Yukio Kondo; Hirohito Yamazaki; Akiyoshi Takami; Masahide Yasui; Hiroshi Date; Shinji Nakao
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

6.  [Clinical analysis of lung transplantation in eight patients with obstructive bronchiolitis syndrome after hematopoietic stem cell transplantation].

Authors:  L L Wang; H Y Wang; Y F Shen; M Z Lu; J Y Chen; B Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-11-14

Review 7.  Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.

Authors:  G C Hildebrandt; T Fazekas; A Lawitschka; H Bertz; H Greinix; J Halter; S Z Pavletic; E Holler; D Wolff
Journal:  Bone Marrow Transplant       Date:  2011-03-28       Impact factor: 5.483
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.